Clinical Trial Update: CM-101 in PSC Patients -The SPRING Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CM-101 in patients with primary sclerosing cholangitis (PSC) is active not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• CM-101

Snippet

Sponsor: ChemomAb Ltd. | Conditions: Primary Sclerosing Cholangitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING